CRON
Cronos Group Inc
NASDAQ: CRON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
-2.64% today
Updated 2026-04-29
Market cap
$1.02B
P/E ratio
—
P/S ratio
6.93x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$2 – $3
Volume
1.5M
Cronos Group Inc (CRON) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.29M | $8.57M | $10.61M | $31.92M | $80.34M | $191.71M | $2.09B | $1.93B | $1.40B | $1.21B | $1.14B | $1.17B |
| Cash & equivalents | $7288.00 | $685293.00 | $812386.00 | $2.58M | $7.32M | $23.96M | $1.20B | $1.08B | $886.97M | $764.64M | $669.29M | $858.80M |
| Current assets | $37288.00 | $1.36M | $882823.00 | $6.02M | $21.24M | $47.77M | $1.57B | $1.37B | $1.08B | $960.16M | $933.31M | $936.11M |
| Total liabilities | $382124.00 | $607045.00 | $2.18M | $6.86M | $11.66M | $36.33M | $341.41M | $217.51M | $63.46M | $72.05M | $44.14M | $55.33M |
| Current liabilities | $382124.00 | $607045.00 | $1.68M | $5.78M | $6.26M | $33.40M | $332.89M | $206.83M | $54.37M | $68.12M | $41.40M | $49.70M |
| Long-term debt | — | $0.00 | $367891.00 | $0.00 | $4.27M | $0.00 | — | — | — | — | — | — |
| Shareholder equity | $905413.00 | $7.96M | $8.43M | $25.06M | $68.68M | $155.29M | $1.75B | $1.71B | $1.34B | $1.14B | $1.10B | $1.06B |
| Retained earnings | $-619475.00 | $-4.68M | $-3.62M | $-4.62M | $-2.96M | $-16.68M | $1.14B | $1.06B | $659.42M | $490.68M | $416.72M | $457.71M |
| Accounts receivable | $617032.00 | $477617.00 | $0.00 | $107000.00 | $1.14M | $5.79M | $16.53M | $26.04M | $33.29M | $31.29M | $35.88M | $29.77M |
| Inventory | — | $17228.00 | $0.00 | $2.76M | $9.65M | $15.17M | $38.04M | $44.00M | $32.80M | $37.56M | $30.50M | $33.15M |
| Goodwill | — | $290267.00 | $282483.00 | $1.33M | $1.43M | $1.32M | $214.49M | $179.52M | $1.10M | $1.03M | $1.06M | $63.45M |